Chief Executive Officer
Mr. Ayni is an entrepreneur and a businessman.
He established Code Pharma company, which develops groundbreaking medical solutions, and accumulated many years of experience in the pharma industry.
Eynat Finkelshtein, PhD.
Chief Scientific Officer
Dr. Finkelshtein is the head of research with a demonstrated history of 15 years of academic and industrial professional experience. She holds a PhD in the field of molecular biology from the Weizmann Institute of Science.
Esmira Naftali, PhD.
Chief Development Officer
Drug development professional and biopharmaceuticals CMC (Chemistry Manufacturing Control) expert with over 20 years of international pharma industry experience in big Pharma and Biotechnology companies. She holds a PhD in Chemistry from University of Latvia, Riga.
About Code Pharma
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.